{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:09:55Z","timestamp":1794442195036,"version":"4.9.1"},"reference-count":42,"publisher":"American Association for Cancer Research (AACR)","issue":"19","license":[{"start":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T00:00:00Z","timestamp":1664841600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C197\/A29580"],"award-info":[{"award-number":["C197\/A29580"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C197\/A17242"],"award-info":[{"award-number":["C197\/A17242"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C9685\/A25177"],"award-info":[{"award-number":["C9685\/A25177"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Early detection of tumor cell death in glioblastoma following treatment with chemoradiation has the potential to distinguish between true disease progression and pseudoprogression. Tumor cell death can be detected noninvasively in vivo by imaging the production of [2,3-2H2]malate from [2,3-2H2]fumarate using 2H magnetic resonance (MR) spectroscopic imaging. We show here that 2H MR spectroscopy and spectroscopic imaging measurements of [2,3-2H2]fumarate metabolism can detect tumor cell death in orthotopically implanted glioblastoma models within 48 hours following the completion of chemoradiation. Following the injection of [2,3-2H2]fumarate into tumor-bearing mice, production of [2,3-2H2]malate was measured in a human cell line\u2013derived model and in radiosensitive and radioresistant patient-derived models of glioblastoma that were treated with temozolomide followed by targeted fractionated irradiation. The increase in the [2,3-2H2]malate\/[2,3-2H2]fumarate signal ratio posttreatment, which correlated with histologic assessment of cell death, was a more sensitive indicator of treatment response than diffusion-weighted and contrast agent\u2013enhanced 1H MRI measurements, which have been used clinically to detect responses of glioblastoma to chemoradiation. Overall, early detection of glioblastoma cell death using 2H MRI of malate production from fumarate could help improve the clinical evaluation of response to chemoradiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>2H magnetic resonance imaging of labeled fumarate metabolism can detect early evidence of tumor cell death following chemoradiation, meeting a clinical need to reliably detect treatment response in glioblastoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-22-0101","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:00:04Z","timestamp":1660644004000},"page":"3622-3633","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Imaging Glioblastoma Response to Radiotherapy Using 2H Magnetic Resonance Spectroscopy Measurements of Fumarate Metabolism"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-7564","authenticated-orcid":false,"given":"Friederike","family":"Hesse","sequence":"first","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4577-5681","authenticated-orcid":false,"given":"Alan J.","family":"Wright","sequence":"additional","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9874-526X","authenticated-orcid":false,"given":"Vencel","family":"Somai","sequence":"additional","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."},{"name":"2Department of Radiology, School of Clinical Medicine, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-9142","authenticated-orcid":false,"given":"Flaviu","family":"Bulat","sequence":"additional","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."},{"name":"3Department of Chemistry, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-3861","authenticated-orcid":false,"given":"Felix","family":"Kreis","sequence":"additional","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3883-6287","authenticated-orcid":false,"given":"Kevin M.","family":"Brindle","sequence":"additional","affiliation":[{"name":"1Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom."},{"name":"4Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"2025112417250571500_bib1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"key":"2025112417250571500_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"key":"2025112417250571500_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2025112417250571500_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"2025112417250571500_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/WCO.0b013e328332363e","article-title":"Pseudoprogression and pseudoresponse in the treatment of gliomas","volume":"22","author":"Brandsma","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"2025112417250571500_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11910-009-0035-4","article-title":"Pseudoprogression and pseudoresponse: challenges in brain tumor imaging","volume":"9","author":"Clarke","year":"2009","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2025112417250571500_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11912-014-0397-x","article-title":"Posttreatment imaging changes in primary brain tumors","volume":"16","author":"O'Brien","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"2025112417250571500_bib8","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ncponc1204","article-title":"Response criteria for glioma","volume":"5","author":"Sorensen","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"2025112417250571500_bib9","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","article-title":"Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group","volume":"28","author":"Wen","year":"2010","journal-title":"J Clin Oncol"},{"key":"2025112417250571500_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2005.12.002","article-title":"Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy","volume":"65","author":"Ruben","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025112417250571500_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jocn.2012.09.011","article-title":"Cerebral radiation necrosis: a review of the pathobiology, diagnosis, and management considerations","volume":"20","author":"Rahmathulla","year":"2013","journal-title":"J Clin Neurosci"},{"key":"2025112417250571500_bib12","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fneur.2019.00460","article-title":"Assessment of glioblastoma response in the era of bevacizumab: longstanding and emergent challenges in the imaging evaluation of pseudoresponse","volume":"10","author":"Arevalo","year":"2019","journal-title":"Front Neurol"},{"key":"2025112417250571500_bib13","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00330-017-4789-9","article-title":"Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis","volume":"27","author":"van Dijken","year":"2017","journal-title":"Eur Radiol"},{"key":"2025112417250571500_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnumed.112.114264","article-title":"Imaging cell death","volume":"55","author":"Neves","year":"2014","journal-title":"J Nucl Med"},{"key":"2025112417250571500_bib15","doi-asserted-by":"crossref","first-page":"19801","DOI":"10.1073\/pnas.0911447106","article-title":"Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors","volume":"106","author":"Gallagher","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"2025112417250571500_bib16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.bjc.6605945","article-title":"Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate","volume":"103","author":"Witney","year":"2010","journal-title":"Br J Cancer"},{"key":"2025112417250571500_bib17","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/1535-7163.MCT-10-0706","article-title":"Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy","volume":"9","author":"Bohndiek","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"2025112417250571500_bib18","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jcmg.2017.09.020","article-title":"Hyperpolarized [1,4-13C2]Fumarate enables magnetic resonance-based imaging of myocardial necrosis","volume":"11","author":"Miller","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025112417250571500_bib19","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1073\/pnas.1205539109","article-title":"Magnetic resonance imaging with hyperpolarized [1,4-(13)C2]fumarate allows detection of early renal acute tubular necrosis","volume":"109","author":"Clatworthy","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025112417250571500_bib20","doi-asserted-by":"crossref","first-page":"e2014631118","DOI":"10.1073\/pnas.2014631118","article-title":"Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging","volume":"118","author":"Hesse","year":"2021","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2025112417250571500_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1667\/RR1845.1","article-title":"CT guidance is needed to achieve reproducible positioning of the mouse head for repeat precision cranial irradiation","volume":"173","author":"Armour","year":"2010","journal-title":"Radiat Res"},{"key":"2025112417250571500_bib22","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1088\/0031-9155\/57\/9\/2575","article-title":"A multipurpose quality assurance phantom for the small animal radiation research platform (SARRP)","volume":"57","author":"Ngwa","year":"2012","journal-title":"Phys Med Biol"},{"key":"2025112417250571500_bib23","first-page":"926","article-title":"Small animal radiation research platform: imaging, mechanics, control, and calibration","volume":"10","author":"Matinfar","year":"2007","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"2025112417250571500_bib24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/jmre.2001.2340","article-title":"The return of the frequency sweep: designing adiabatic pulses for contemporary NMR","volume":"153","author":"Garwood","year":"2001","journal-title":"J Magn Reson"},{"key":"2025112417250571500_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/jmre.1997.1244","article-title":"Improved method for accurate and efficient quantification of MRS data with use of prior knowledge","volume":"129","author":"Vanhamme","year":"1997","journal-title":"J Magn Reson"},{"key":"2025112417250571500_bib26","doi-asserted-by":"crossref","first-page":"e0185356","DOI":"10.1371\/journal.pone.0185356","article-title":"OXSA: an open-source magnetic resonance spectroscopy analysis toolbox in MATLAB","volume":"12","author":"Purvis","year":"2017","journal-title":"PLoS One"},{"key":"2025112417250571500_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1148\/radiol.2019191242","article-title":"Measuring tumor glycolytic flux in vivo by using fast deuterium MRI","volume":"294","author":"Kreis","year":"2020","journal-title":"Radiology"},{"key":"2025112417250571500_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0045-2068(71)90018-6","article-title":"Relationships of pH to exchange rates and deuterium isotope effects in the fumarase reaction","volume":"1","author":"Berman","year":"1971","journal-title":"Bioorg Chem"},{"key":"2025112417250571500_bib29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/mrm.26779","article-title":"Quantitative Gd-DOTA uptake from cerebrospinal fluid into rat brain using 3D VFA-SPGR at 9.4 T","volume":"79","author":"Lee","year":"2018","journal-title":"Magn Reson Med"},{"key":"2025112417250571500_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"2025112417250571500_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2020.08.016","article-title":"Metabolic imaging detects resistance to PI3K\u03b1 inhibition mediated by persistent FOXM1 expression in ER+ breast cancer","volume":"38","author":"Ros","year":"2020","journal-title":"Cancer Cell"},{"key":"2025112417250571500_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jon.12687","article-title":"Clinical imaging for diagnostic challenges in the management of gliomas: a review","volume":"30","author":"Bonm","year":"2020","journal-title":"J Neuroimaging"},{"key":"2025112417250571500_bib33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jmri.26171","article-title":"Pseudoprogression of brain tumors","volume":"48","author":"Thust","year":"2018","journal-title":"J Magn Reson Imaging"},{"key":"2025112417250571500_bib34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmri.25159","article-title":"Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas","volume":"44","author":"Ma","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"2025112417250571500_bib35","first-page":"912","article-title":"Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis","volume":"51","author":"Rock","year":"2002","journal-title":"Neurosurgery"},{"key":"2025112417250571500_bib36","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1227\/01.NEU.0000119328.56431.A7","article-title":"Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis","volume":"54","author":"Rock","year":"2004","journal-title":"Neurosurgery"},{"key":"2025112417250571500_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nicl.2016.02.016","article-title":"Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of MR spectroscopy and diffusion-weighted MR imaging","volume":"11","author":"Kazda","year":"2016","journal-title":"Neuroimage Clin"},{"key":"2025112417250571500_bib38","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CCO.0000000000000793","article-title":"Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis","volume":"33","author":"Nichelli","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"2025112417250571500_bib39","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1073\/pnas.1733835100","article-title":"Increase in signal-to-noise ratio of &gt;10,000 times in liquid-state NMR","volume":"100","author":"Ardenkjaer-Larsen","year":"2003","journal-title":"Proc Nat Acad Sci U S A"},{"key":"2025112417250571500_bib40","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-18-0759","article-title":"Metabolic imaging detects low levels of glycolytic activity that vary with levels of c-myc expression in patient-derived xenograft models of glioblastoma","volume":"78","author":"Mair","year":"2018","journal-title":"Cancer Res"},{"key":"2025112417250571500_bib41","doi-asserted-by":"crossref","first-page":"eaat7314","DOI":"10.1126\/sciadv.aat7314","article-title":"Deuterium metabolic imaging (DMI) for MRI-based 3D mapping of metabolism in vivo","volume":"4","author":"De Feyter","year":"2018","journal-title":"Sci Adv"},{"key":"2025112417250571500_bib42","doi-asserted-by":"crossref","first-page":"e4235","DOI":"10.1002\/nbm.4235","article-title":"On the magnetic field dependence of deuterium metabolic imaging","volume":"33","author":"de Graaf","year":"2020","journal-title":"NMR Biomed"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-22-0101\/3190117\/can-22-0101.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/19\/3622\/3209790\/3622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/19\/3622\/3209790\/3622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:27:18Z","timestamp":1764023238000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/19\/3622\/709416\/Imaging-Glioblastoma-Response-to-Radiotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":42,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,8,16]]},"published-print":{"date-parts":[[2022,10,4]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-0101","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6514140.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432392.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514140","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30699269","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699266","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699278","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432392","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699275","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699287","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699284","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699272","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699281","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}